| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 59.997 | 0 | 3.101 | 18.108 | 1.521 | 0 | 0 |
| Total Income - EUR | - | - | - | 59.997 | 0 | 3.101 | 18.108 | 1.558 | 4 | 6 |
| Total Expenses - EUR | - | - | - | 16.310 | 774 | 806 | 63.212 | 44.727 | 11.484 | 166 |
| Gross Profit/Loss - EUR | - | - | - | 43.687 | -774 | 2.295 | -45.103 | -43.169 | -11.480 | -160 |
| Net Profit/Loss - EUR | - | - | - | 41.887 | -774 | 2.202 | -45.519 | -43.183 | -11.480 | -160 |
| Employees | - | - | - | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Vth Invest Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 42.038 | 40.386 | 41.916 | 48.805 | 49.157 | 10.576 | 19.375 |
| Inventories | - | - | - | 0 | 0 | 0 | 6.480 | 6.074 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 3.101 | 6.262 | 11.443 | 10.313 | 19.257 |
| Cash | - | - | - | 42.038 | 40.386 | 38.815 | 36.063 | 31.640 | 262 | 118 |
| Shareholders Funds | - | - | - | 41.973 | 40.386 | 41.823 | -4.624 | -47.822 | -59.157 | -58.986 |
| Social Capital | - | - | - | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | - | - | 64 | 0 | 93 | 53.516 | 96.978 | 69.733 | 78.361 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
6831
|
|||||||||
Comments - Vth Invest Pharma S.r.l.